The Short Answer: It Depends on Why It’s Prescribed
Whether Medicare Part D covers a GLP-1 medication like semaglutide (marketed as Ozempic or Wegovy, depending on the approved use) or tirzepatide depends significantly on the specific reason it’s prescribed — diabetes management versus weight loss are treated differently under current Medicare rules. This content is for educational purposes only and does not constitute medical advice. Consult your healthcare provider for medical decisions.
Diabetes-Indicated Use
GLP-1 medications approved and prescribed specifically for type 2 diabetes management are generally eligible for Part D coverage, subject to your specific plan’s formulary, tier placement, and any prior authorization requirements. Coverage and cost-sharing still vary by plan, so checking your specific formulary matters even within this category.
Weight-Loss-Indicated Use
Historically, Medicare Part D has excluded coverage for medications used specifically for weight loss, since weight-loss drugs as a category were excluded under the original Part D statute. This has been an evolving area — coverage rules around GLP-1 medications prescribed for obesity, particularly where there’s a documented related medical condition like cardiovascular risk, have been the subject of ongoing policy discussion and change. Because this is genuinely a moving target, verifying your specific plan’s current formulary and any recent policy updates directly, rather than relying on general information, is the most reliable approach.
What Drives the Cost Difference
Because of these coverage rules, the same medication can have a dramatically different out-of-pocket cost depending on the documented reason for the prescription and how it’s coded — which is part of why this is worth discussing directly with both your doctor and your plan.
How to Check Your Specific Coverage
- Review your Part D or Medicare Advantage plan’s current formulary for the specific medication and dosage
- Ask your prescribing doctor how the prescription will be coded, since this affects coverage eligibility
- Contact your plan directly to confirm current coverage and any prior authorization requirements before assuming a cost
Reviewing During AEP
If GLP-1 medication access or cost has been a significant factor in your healthcare experience this year, it’s worth specifically evaluating formulary coverage for these medications when comparing plans during the Annual Enrollment Period (AEP 2026, October 15 – December 7), since coverage can differ meaningfully between plans.
Have questions about your specific Part D coverage? Schedule a free review with Kayla Price, a licensed insurance agent at Price Services Group. Call 866-648-1578 or visit priceservicesgroup.com/schedule.
Price Services Group, LLC is not affiliated with or endorsed by the U.S. government or the federal Medicare program. NPN: 18530055 | Agency NPN: 20387435